Article: Other News To Note.

ActivX Biosciences Inc., of La Jolla, Calif., reported publication in the July 30, 2002, issue of the Proceedings of the National Academy of Sciences describing the design and use of activity-based chemical probes licensed exclusively by ActivX and The Scripps Research Institute. A second article, in the August 2002 issue of Nature Biotechnology, reports on the use of combinatorial approaches to generate activity-based chemical probes for interrogating biological samples.

ARC Pharmaceuticals Inc., of Vancouver, British Columbia, entered a research agreement with McGill University in Montreal to support the development of antisense oligonucleotide therapeutics for ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!